Related Experiment Video

Updated: May 24, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Heat shock protein 90 inhibitors as therapeutic agents

Isabel Gomez-Monterrey1, Marina Sala, Simona Musella

  • 1Dipartimento di Chimica Farmaceutica e Tossicologica, Universita di Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy. imgomez@unina.it

Recent Patents on Anti-Cancer Drug Discovery
|February 18, 2012
PubMed

Insights

Heat shock protein 90 (HSP90) is crucial for cancer cell growth. Inhibiting HSP90 offers a promising strategy to block multiple cancer pathways, with several HSP90 inhibitors in clinical trials.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Heat shock protein 90 (HSP90) is a molecular chaperone vital for cancer cell growth, survival, and tumor transformation.
  • HSP90 regulates key proteins involved in cell growth, differentiation, and survival, making it a target for cancer therapy.

Purpose of the Study:

  • To review the current progress in the development of HSP90 inhibitors for cancer treatment.
  • To discuss recent patents related to HSP90 inhibitors in drug discovery.

Main Methods:

  • Review of scientific literature and recent patents on HSP90 inhibitors.
  • Analysis of HSP90 inhibitors targeting different domains (N-terminal ATP pocket, C-terminal), isoforms, and interactions (cochaperones, client proteins).

Main Results:

  • HSP90 inhibition provides a combinatorial blockade of oncogenic pathways, counteracting cancer hallmarks.
  • Several HSP90 inhibitors are under clinical investigation for various cancer types.
  • Recent patents highlight advancements in HSP90 inhibitor drug discovery.

Conclusions:

  • HSP90 inhibitors represent a promising therapeutic strategy for cancer treatment.
  • Targeting HSP90 offers a way to antagonize multiple cancer-driving pathways simultaneously.
  • Continued research and development in HSP90 inhibitor drug discovery are crucial for advancing cancer therapy.

More Related Videos

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...